Good morning :)
Place Order
Add to Watchlist

Lotus Eye Hospital and Institute Ltd

LOTUSEYE Share Price

73.051.14% (-0.84)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP

With a market cap of ₹151 cr, stock is ranked 2,726

Stock is 3.51x as volatile as Nifty

LOTUSEYE Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

With a market cap of ₹151 cr, stock is ranked 2,726

Stock is 3.51x as volatile as Nifty

LOTUSEYE Performance & Key Metrics

LOTUSEYE Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
213.972.56
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
36.686.410.79%

LOTUSEYE Analyst Ratings & Forecast

Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

LOTUSEYE Company Profile

Lotus Eye Hospital and Institute Limited is engaged in the provision of healthcare services. The Company is engaged in the field of ophthalmology (eye) and its related operation.

LOTUSEYE Similar Stocks (Peers)

Compare with peers Compare with peers 

LOTUSEYE Similar Stocks (Peers)

Compare with peers Compare with peers 
PE Ratio
110.16
110.16
1Y Return
35.87%
35.87%
Buy Reco %
75.00
75.00
PE Ratio
71.49
71.49
1Y Return
12.53%
12.53%
Buy Reco %
89.66
89.66
PE Ratio
74.55
74.55
1Y Return
62.57%
62.57%
Buy Reco %
92.86
92.86
PE Ratio
51.59
51.59
1Y Return
62.55%
62.55%
Buy Reco %
70.00
70.00
PE Ratio
72.76
72.76
1Y Return
4.53%
4.53%
Buy Reco %
71.43
71.43
Compare with Peers

LOTUSEYE Forecast

LOTUSEYE Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

LOTUSEYE

LOTUSEYE

Income

Balance Sheet

Cash Flow

LOTUSEYE Income Statement

LOTUSEYE Income Statement

Industry refers to the sub-sector this company belongs to.
Lower than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 4.17%, vs industry avg of 12.84%

Decreasing Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 0.1% to 0.06%

Lower than Industry Net Income
Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of -7.01%, vs industry avg of 41.11%

Loading...

Financial YearFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Total Revenue34.6738.9339.1141.4833.2039.8048.1949.5250.8750.88
Raw Materialssubtract10.2710.896.186.114.765.696.937.0546.1346.14
Power & Fuel Costsubtract0.981.111.241.220.960.851.031.38
Employee Costsubtract7.007.788.498.176.826.988.529.25
Selling & Administrative Expensessubtract5.526.336.386.514.065.185.966.17
Operating & Other expensessubtract6.897.5612.9215.2912.1414.2916.9117.73
Depreciation/Amortizationsubtract3.443.373.062.502.332.502.983.733.013.02
Interest & Other Itemssubtract0.150.180.210.240.140.210.200.200.360.36
Taxes & Other Itemssubtract-0.03-0.04-0.080.390.421.111.571.100.640.65
EPS0.220.840.340.500.751.441.971.400.360.34
DPS0.500.500.000.000.500.500.500.000.000.00
Payout ratio2.310.590.000.000.660.350.250.000.000.00

LOTUSEYE Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2024FY 2024

Annual report

PDF
FY 2023FY 2023

Annual report

PDF
FY 2022FY 2022

Annual report

PDF

Investor Presentation

Jul 3PDF
FY 2021FY 2021

Annual report

PDF

Investor Presentation

Feb 9PDF
FY 2020FY 2020

Annual report

PDF
FY 2019FY 2019

Annual report

PDF
FY 2018FY 2018

Annual report

PDF
FY 2017FY 2017

Annual report

PDF
FY 2016FY 2016

Annual report

PDF
FY 2015FY 2015

Annual report

PDF
 

LOTUSEYE Stock Peers

LOTUSEYE Past Performance & Peer Comparison

LOTUSEYE Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CareHospitals & Diagnostic Centres

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Lotus Eye Hospital and Institute Ltd208.112.56
Max Healthcare Institute Ltd110.1612.630.12%
Apollo Hospitals Enterprise Ltd71.4914.120.39%
Fortis Healthcare Ltd74.556.750.13%

LOTUSEYE Stock Price Comparison

Compare LOTUSEYE with any stock or ETF
Compare LOTUSEYE with any stock or ETF
LOTUSEYE
Loading...

LOTUSEYE Holdings

LOTUSEYE Shareholdings

LOTUSEYE Promoter Holdings Trend

LOTUSEYE Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

LOTUSEYE Institutional Holdings Trend

LOTUSEYE Institutional Holdings Trend

Decreased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has decreased by 1.77%

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

LOTUSEYE Shareholding Pattern

LOTUSEYE Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding40.39%0.00%0.02%0.01%59.58%

Sep 2024

Dec 2024

Mar 2025

Jun 2025

LOTUSEYE Shareholding History

LOTUSEYE Shareholding History

MarJunSepDec '24MarJun0.00%0.00%0.00%0.00%0.00%0.01%

LOTUSEYE Insider Trades & Bulk Stock Deals

LOTUSEYE Insider Trades & Bulk Stock Deals

Loading...

smallcases containing LOTUSEYE stock

smallcases containing LOTUSEYE stock

Looks like this stock is not in any smallcase yet.

LOTUSEYE Events

LOTUSEYE Events

LOTUSEYE Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

LOTUSEYE Dividend Trend

No dividend trend available

LOTUSEYE Upcoming Dividends

LOTUSEYE Upcoming Dividends

No upcoming dividends are available

LOTUSEYE Past Dividends

LOTUSEYE Past Dividends

Cash Dividend

Ex DateEx DateSep 18, 2023

Final
Final | Div/Share: ₹0.50

Dividend/Share

0.50

Ex DateEx Date

Sep 18, 2023

Cash Dividend

Ex DateEx DateSep 8, 2022

Final
Final | Div/Share: ₹0.50

Dividend/Share

0.50

Ex DateEx Date

Sep 8, 2022

Cash Dividend

Ex DateEx DateSep 8, 2021

Final
Final | Div/Share: ₹0.50

Dividend/Share

0.50

Ex DateEx Date

Sep 8, 2021

Cash Dividend

Ex DateEx DateSep 14, 2018

Final
Final | Div/Share: ₹0.50

Dividend/Share

0.50

Ex DateEx Date

Sep 14, 2018

Cash Dividend

Ex DateEx DateAug 2, 2017

Final
Final | Div/Share: ₹0.50

Dividend/Share

0.50

Ex DateEx Date

Aug 2, 2017

LOTUSEYE Stock News & Opinions

LOTUSEYE Stock News & Opinions

Earnings
Lotus Eye Hospital & Institute standalone net profit rises 1150.00% in the March 2025 quarter

Net profit of Lotus Eye Hospital & Institute rose 1150.00% to Rs 0.25 crore in the quarter ended March 2025 as against Rs 0.02 crore during the previous quarter ended March 2024. Sales rose 5.79% to Rs 11.51 crore in the quarter ended March 2025 as against Rs 10.88 crore during the previous quarter ended March 2024. For the full year,net profit declined 74.57% to Rs 0.74 crore in the year ended March 2025 as against Rs 2.91 crore during the previous year ended March 2024. Sales rose 2.80% to Rs 49.56 crore in the year ended March 2025 as against Rs 48.21 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales11.5110.88 6 49.5648.21 3 OPM %-1.486.89 -6.9413.54 - PBDT0.251.12 -78 4.387.73 -43 PBT0.830 0 1.374.00 -66 NP0.250.02 1150 0.742.91 -75 Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Lotus Eye Hospital & Institute to discuss results

Lotus Eye Hospital & Institute will hold a meeting of the Board of Directors of the Company on 29 May 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Spotlight
Lotus Eye Hospital & Institute Ltd leads gainers in 'B' group

Country Condos Ltd, Hexa Tradex Ltd, Jagsonpal Pharmaceuticals Ltd and SEL Manufacturing Company Ltd are among the other gainers in the BSE's 'B' group today, 25 April 2025.Lotus Eye Hospital & Institute Ltd spiked 13.27% to Rs 76.75 at 12:02 IST. The stock was the biggest gainer in the BSE's 'B' group. On the BSE, 22653 shares were traded on the counter so far as against the average daily volumes of 3096 shares in the past one month. Country Condos Ltd soared 9.92% to Rs 10.97. The stock was the second biggest gainer in 'B' group. On the BSE, 5.63 lakh shares were traded on the counter so far as against the average daily volumes of 1.25 lakh shares in the past one month. Hexa Tradex Ltd surged 6.95% to Rs 210.9. The stock was the third biggest gainer in 'B' group. On the BSE, 50 shares were traded on the counter so far as against the average daily volumes of 753 shares in the past one month. Jagsonpal Pharmaceuticals Ltd rose 6.69% to Rs 255.2. The stock was the fourth biggest gainer in 'B' group. On the BSE, 1.83 lakh shares were traded on the counter so far as against the average daily volumes of 9340 shares in the past one month. SEL Manufacturing Company Ltd exploded 4.98% to Rs 42.18. The stock was the fifth biggest gainer in 'B' group. On the BSE, 17410 shares were traded on the counter so far as against the average daily volumes of 6034 shares in the past one month. Powered by Capital Market - Live

2 months agoCapital Market - Live
Earnings
Lotus Eye Hospital & Institute reports standalone net loss of Rs 0.24 crore in the December 2024 quarter

Net loss of Lotus Eye Hospital & Institute reported to Rs 0.24 crore in the quarter ended December 2024 as against net profit of Rs 0.66 crore during the previous quarter ended December 2023. Sales rose 1.83% to Rs 12.25 crore in the quarter ended December 2024 as against Rs 12.03 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales12.2512.03 2 OPM %6.4513.13 - PBDT0.881.89 -53 PBT-0.430.91 PL NP-0.240.66 PL Powered by Capital Market - Live

4 months agoCapital Market - Live
Earnings
Lotus Eye Hospital & Institute standalone net profit declines 88.24% in the September 2024 quarter

Net profit of Lotus Eye Hospital & Institute declined 88.24% to Rs 0.10 crore in the quarter ended September 2024 as against Rs 0.85 crore during the previous quarter ended September 2023. Sales rose 1.41% to Rs 12.91 crore in the quarter ended September 2024 as against Rs 12.73 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales12.9112.73 1 OPM %8.9114.22 - PBDT1.342.07 -35 PBT0.111.18 -91 NP0.100.85 -88 Powered by Capital Market - Live

7 months agoCapital Market - Live
Corporate
Lotus Eye Hospital & Institute to discuss results

Lotus Eye Hospital & Institute will hold a meeting of the Board of Directors of the Company on 12 November 2024Powered by Capital Market - Live

8 months agoCapital Market - Live
Earnings
Lotus Eye Hospital & Institute standalone net profit declines 55.07% in the June 2024 quarter

Net profit of Lotus Eye Hospital & Institute declined 55.07% to Rs 0.62 crore in the quarter ended June 2024 as against Rs 1.38 crore during the previous quarter ended June 2023. Sales rose 2.55% to Rs 12.89 crore in the quarter ended June 2024 as against Rs 12.57 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales12.8912.57 3 OPM %12.9618.93 - PBDT1.922.64 -27 PBT0.861.91 -55 NP0.621.38 -55 Powered by Capital Market - Live

10 months agoCapital Market - Live
Corporate
Lotus Eye Hospital & Institute to convene AGM

Lotus Eye Hospital & Institute announced that the 27th Annual General Meeting (AGM) of the company will be held on 13 August 2024.Powered by Capital Market - Live

11 months agoCapital Market - Live

BRIEF-Lotus Eye Hospital And Institute - Names Kavetha Sundaramoorthy As Chairman - Investing.com India

4 years agoInvesting.com

BRIEF-Lotus Eye Hospital And Institute Ltd - Approved Appointment Of K.S. Ramalingam As CEO - Investing.com India

4 years agoInvesting.com

Frequently asked questions

Frequently asked questions

  1. What is the share price of Lotus Eye Hospital and Institute Ltd (LOTUSEYE) today?

    The share price of LOTUSEYE as on 11th July 2025 is ₹73.05. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Lotus Eye Hospital and Institute Ltd (LOTUSEYE) share?

    The past returns of Lotus Eye Hospital and Institute Ltd (LOTUSEYE) share are
    • Past 1 week: 4.20%
    • Past 1 month: 0.83%
    • Past 3 months: 13.29%
    • Past 6 months: 11.63%
    • Past 1 year: 23.90%
    • Past 3 years: 37.18%
    • Past 5 years: 131.17%

  3. What are the peers or stocks similar to Lotus Eye Hospital and Institute Ltd (LOTUSEYE)?
  4. What is the market cap of Lotus Eye Hospital and Institute Ltd (LOTUSEYE) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Lotus Eye Hospital and Institute Ltd (LOTUSEYE) is ₹151.92 Cr as of 11th July 2025.

  5. What is the 52 week high and low of Lotus Eye Hospital and Institute Ltd (LOTUSEYE) share?

    The 52-week high of Lotus Eye Hospital and Institute Ltd (LOTUSEYE) is ₹90.98 and the 52-week low is ₹54.99.

  6. What is the PE and PB ratio of Lotus Eye Hospital and Institute Ltd (LOTUSEYE) stock?

    The P/E (price-to-earnings) ratio of Lotus Eye Hospital and Institute Ltd (LOTUSEYE) is 208.11. The P/B (price-to-book) ratio is 2.56.

  7. Which sector does Lotus Eye Hospital and Institute Ltd (LOTUSEYE) belong to?

    Lotus Eye Hospital and Institute Ltd (LOTUSEYE) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.

  8. How to buy Lotus Eye Hospital and Institute Ltd (LOTUSEYE) shares?

    You can directly buy Lotus Eye Hospital and Institute Ltd (LOTUSEYE) shares on Tickertape. Simply sign up, connect your demat account and place your order.